Business Description
Alamar Biosciences Inc
NAICS : 325413
SIC : 2836
ISIN : US0109111056
Description
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.86 | |||||
Equity-to-Asset | 0.8 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | -1.64 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 14.91 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Future 3-5Y Total Revenue Growth Rate Estimate | 44.04 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 77.1 | |||||
9-Day RSI | 62.61 | |||||
14-Day RSI | 57.87 | |||||
3-1 Month Momentum % | 59.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 11.85 | |||||
Quick Ratio | 10.23 | |||||
Cash Ratio | 8.94 | |||||
Days Inventory | 646.93 | |||||
Days Sales Outstanding | 115.43 | |||||
Days Payable | 132.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 58.01 | |||||
Operating Margin % | -46.66 | |||||
Net Margin % | -62.25 | |||||
EBITDA Margin % | -56.62 | |||||
FCF Margin % | -64.75 | |||||
OCF Margin % | -57.1 | |||||
ROA % | -14.44 | |||||
ROIC % | -23.84 | |||||
ROC (Joel Greenblatt) % | -36.76 | |||||
ROCE % | -15.76 | |||||
Moat Score | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 35.35 | |||||
PB Ratio | 7.1 | |||||
Price-to-Tangible-Book | 7.13 | |||||
EV-to-EBIT | -59.78 | |||||
EV-to-EBITDA | -64.16 | |||||
EV-to-Revenue | 36.33 | |||||
EV-to-Forward-Revenue | 11.18 | |||||
EV-to-FCF | -56.11 | |||||
| Price-to-Net-Current-Asset-Value | 8.77 | |||||
| Price-to-Net-Cash | 12.91 | |||||
Earnings Yield (Greenblatt) % | -1.67 | |||||
FCF Yield % | -1.62 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ALMR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Alamar Biosciences Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 55.462 | ||
| EPS (TTM) ($) | -0.498 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 57.87 | ||
| 14-Day ATR ($) | 2.122476 | ||
| 20-Day SMA ($) | 30.843 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 18.845 - 38.54 | ||
| Shares Outstanding (Mil) | 69.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Alamar Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Alamar Biosciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Alamar Biosciences Inc Frequently Asked Questions
What is Alamar Biosciences Inc(ALMR)'s stock price today?
The current price of ALMR is $32.02. The 52 week high of ALMR is $38.54 and 52 week low is $18.85.
When is next earnings date of Alamar Biosciences Inc(ALMR)?
The next earnings date of Alamar Biosciences Inc(ALMR) is .
Does Alamar Biosciences Inc(ALMR) pay dividends? If so, how much?
Alamar Biosciences Inc(ALMR) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Precision Proteomics Leader Alamar Biosciences Lists on NASDAQ | 2026-04-20 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers